7 reports

Other revenue reached ™ ## million from ™ ## million in 2017, due to the one-time other revenue in 2017 of ™ ## million for out-licensing of the overthe-counter allergy drug Xyzal® (levoceterizine) in the U. S.

  • Clinical Trial
  • Pharmaceutical
  • Psychotic Disorder
  • United States
  • Company

The company is developing Staccato alprazolam, a drug-device combination product that provides rapid systemic delivery through inhalation.

  • Psychotic Disorder
  • United States
  • Corporate Finance
  • Market Shares
  • Alexza Pharmaceuticals, Inc.

One patch was loaded with drug-containing nanoparticles, and the other patch held no drugs.

  • Clinical Trial
  • Psychotic Disorder
  • United States
  • Company
  • Aequus Pharmaceuticals Inc.

CY-## - DRUG PROFILE DORA-## - DRUG PROFILE DRGT-## - DRUG PROFILE DRUG FOR INSOMNIA - DRUG PROFILE DRUGS TO INHIBIT ANGIOTENSIN II RECEPTOR TYPE ## FOR INSOMNIA - DRUG PROFILE EVT-## - DRUG PROFILE Drug Name C

  • Psychotic Disorder
  • Sleep Aid
  • United States
  • World
  • Product Initiative

DRUGS TO INHIBIT ANGIOTENSIN II RECEPTOR TYPE ## FOR INSOMNIA - DRUG PROFILE Drugs to Inhibit Angiotensin II Receptor Type ## for Insomnia Drug Name Company/ Institute Name Licensed From Company Development Partner Product Description Universit

  • Pharmaceutical
  • Psychotic Disorder
  • Sleep Aid
  • United States
  • Product Initiative

Food and Drug Administration' s (FDA) Pulmonary- Allergy Drugs Advisory Committee recommended approval of reslizumab, in adult patients aged ## years and older.

  • Psychotic Disorder
  • United States
  • Auspex Pharmaceuticals, Inc.
  • Cephalon, Inc.
  • ChemGenex Pharmaceuticals Limited

EXTERNAL STIMULI SUCH AS SKIN TRAUMA, INFECTION, ALLERGY AND DRUGS MAY TRIGGER THE DISEASE.

  • Clinical Trial
  • Hospital
  • Psychotic Disorder
  • United States
  • Pfizer Inc.